The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents

Authors: Tran, Huong Chi Mai, Mbemba, Elisabeth, Mourot, Noémie, Faltas, Beshoy, Rousseau, Aurélie, Lefkou, Elmina, Sabbah, Michèle, van Dreden, Patrick, Gerotziafas, Grigoris

Source: In Thrombosis Research June 2024 238:172-183

Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival

Authors: Doubre, Helene, Monnet, Isabelle, Azarian, Reza, Girard, Philippe, Meyer, Guy, Trichereau, Julie, Devillier, Philippe, Van Dreden, Patrick, Couderc, Louis-Jean, Chouaid, Christos, Vasse, Marc

Source: In Research and Practice in Thrombosis and Haemostasis February 2024 8(2)

Tissue factor pathway-related biomarkers in liver cancer: activated factor VII–antithrombin complex and tissue factor mRNA levels are associated with mortality

Authors: Martinelli, Nicola, Moruzzi, Sara, Udali, Silvia, Castagna, Annalisa, Di Santo, Laura, Ambrosani, Francesca, Baroni, Marcello, Pattini, Patrizia, Pizzolo, Francesca, Ruzzenente, Andrea, Conci, Simone, Grusse, Matthieu, Campagnaro, Tommaso, Van Dreden, Patrick, Guglielmi, Alfredo, Bernardi, Francesco, Olivieri, Oliviero, Friso, Simonetta

Source: In Research and Practice in Thrombosis and Haemostasis January 2024 8(1)

Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer

Authors: Gerotziafas, Grigoris T. ^*, Mahé, Isabelle, Lefkou, Eleftheria, AboElnazar, Essam, Abdel-Razeq, Hiqmat, Taher, Ali, Antic, Darko, Elalamy, Ismail, Syrigos, Kostas, Van Dreden, Patrick

Source: In Thrombosis Research July 2020 191 Supplement 1:S50-S57

Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells

Authors: AmraneDjedidi, Rania, Rousseau, Aurélie, Larsen, Annette K., Elalamy, Ismail, Van Dreden, Patrick, Gerotziafas, Grigoris T.

Source: In Thrombosis Research March 2020 187:170-179

Recommandations pour la prise en charge des patients atteints de la Covid-19 avec maladie vasculaire ou présentant des facteurs de risque cardiovasculaire Fondation VAS (European Independent Foundation in Angiology/Vascular Medicine)

Authors: Gerotziafas, Grigoris T., Van Dreden, Patrick, Catalano, Mariella, Colgan, Mary-Paula, Pecsvarady, Zsolt, Wautrecht, Jean-Claude, Fazeli, Bahare, Olinic, Dan-Mircea, Farkas, Katalin

Source: STV. 32(6):241-259

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN625904892&indx=1&recIds=ETOCRN625904892

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots

Authors: Salta, Stella, Papageorgiou, Loula, Larsen, Annette K., Van Dreden, Patrick, Soulier, Claire, Cokkinos, Dennis V., Elalamy, Ismail, Gerotziafas, Grigoris T. ^*

Source: In Research and Practice in Thrombosis and Haemostasis October 2018 2(4):696-707

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

Authors: Papageorgiou, Loula, Alhaj Hussen, Kutaiba, Thouroude, Sandrine, Mbemba, Elisabeth, Cost, Héléne, Garderet, Laurent, Elalamy, Ismail, Larsen, Annette, Van Dreden, Patrick, Dimopoulos, Meletios, Mohty, Mohamad, Gerotziafas, Grigoris

Source: TH open. 03(04):e340-e347

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186816415.0x000001&indx=1&recIds=ETOCvdc_100186816415.0x000001

Graft Product for Autologous Peripheral Blood Stem Cell Transplantation Enhances Thrombin Generation and Expresses Procoagulant Microparticles and Tissue Factor

Authors: Sidibe, Fatoumata, Spanoudaki, Anastasia, Vanneaux, Valerie, Mbemba, Elisabeth, Larghero, Jerome, Van Dreden, Patrick, Lotz, Jean-Pierre, Elalamy, Ismail, Larsen, Annette K., Gerotziafas, Grigoris T.

Source: Clinical and applied thrombosis/hemostasis. 24(4):684-690

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN617185529&indx=1&recIds=ETOCRN617185529

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

Authors: Syrigos, Konstantinos, Grapsa, Dimitra, Sangare, Rabiatou, Evmorfiadis, Ilias, Larsen, Annette K., Van Dreden, Patrick, Boura, Paraskevi, Charpidou, Andriani, Kotteas, Elias, Sergentanis, Theodoros N., Elalamy, Ismail, Falanga, Anna, Gerotziafas, Grigoris T.

Source: Oncologist. 23(11):1372-1381

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100082763878.0x000001&indx=1&recIds=ETOCvdc_100082763878.0x000001

Decreased levels of procoagulant phospholipids in bleeding patients treated by vitamin K antagonists

Authors: Mathieu, Emmanuel, Van Dreden, Patrick, Aulagnier, Jérôme, Grusse, Matthieu, Dreyfus, Jean-François, François, Dominique, Vasse, Marc

Source: In Thrombosis Research January 2016 137:36-40

Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin

Authors: Rousseau, Aurélie, Van Dreden, Patrick, Mbemba, Elisabeth, Elalamy, Ismail, Larsen, Annette, Gerotziafas, Grigoris T.

Source: In Thrombosis Research December 2015 136(6):1273-1279

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study

Authors: Gerotziafas, Grigoris, Van Dreden, Patrick, Mathieu d'Argent, Emmanuelle, Lefkou, Eleftheria, Grusse, Matthieu, Comtet, Marjorie, Sangare, Rabiatou, Ketatni, Hela, Larsen, Annette, Elalamy, Ismail

Source: Thrombosis journal. 15(1):1-11

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100117591087.0x000001&indx=1&recIds=ETOCvdc_100117591087.0x000001

The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROVI

Authors: Sassi, Mouna, Chakroun, Taher, Mbemba, Elisabeth, Van Dreden, Patrick, Elalamy, Ismail, Larsen, Annette K., Gerotziafas, Grigoris T.

Source: Clinical and applied thrombosis/hemostasis. 23(2):155-163

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN609983734&indx=1&recIds=ETOCRN609983734

Profile of Perioperative Coagulation in Major Liver Resection for Cancer: A Prospective Observational Study

Authors: Van Dreden, Patrick, Tzimas, Petros ^*, Lefkou, Eleftheria ^*, Karakosta, Agathi ^*, Argyron, Stellios ^*, Papapetrou, Evangelia ^*, Pantazi, Despoina ^*, Tselepis, Alexandros ^*, Stratigopoulou, Panagiota ^*, Glantzounis, Georgios ^*, Kalantzi, Kallirroi ^*, Gerotziafas, Grigorios T. ^*

Source: In Blood 15 November 2022 140 Supplement 1:11205-11207

Persisting Endothelial Cell Activation and Hypercoagulability after Recovering from COVID-19: The Roadmap-Post COVID-19 Study

Authors: Van Dreden, Patrick, Terpos, Evangelos, Politou, Marianna ^*, Dimopoulos, Meletios A., Grusse, Matthieu ^*, Gerotziafas, Grigorios T. ^*

Source: In Blood 15 November 2022 140 Supplement 1:2783-2785

Characterization of the Antithrombotic Fingerprint of the Branded and Copies of the Low-Molecular-Weight Enoxaparin Using Thrombin Generation Assay

Authors: Gerotziafas, Grigoris T., Rouseau, Aurèlie, Mbemba, Elisabeth, Khartechi, Amir, Van Dreden, Patrick, Walenga, Janine, Fareed, Jawed, Elalamy, Ismail

Source: Clinical and applied thrombosis/hemostasis. 21(8):697-704

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN603191352&indx=1&recIds=ETOCRN603191352

The procoagulant phospholipid dependent clotting time and the initiation phase of thrombin generation test are mandatory for the evaluation of the risk for severe early onset preeclampsia

Authors: Van Dreden, Patrick, Lefkou, Eleftheria, Ka, Aboubakar, Sfakianoudis, Konstantinos, Rousseau, Aurélie, Geroziafas, Grigoris T.

Source: In Thrombosis Research September 2022 217:57-59

Decreased procoagulant phospholipids in patients treated by vitamin K antagonists

Authors: Rousseau, Aurélie, Woodhams, Barry, Paunet-Bobo, Michèle, Van Dreden, Patrick, Bigot, Dany, Leclerc, Sylviane, Lenormand, Bernard, Vasse, Marc

Source: In Thrombosis Research September 2012 130(3):491-494

Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: The cause of hypercoagulability?

Authors: Van Dreden, Patrick, Woodhams, Barry, Rousseau, Aurélie, Favier, Marie, Favier, Remi

Source: In Thrombosis Research June 2012 129(6):787-792